Showing results (61-70 of 179) with videos related to

Sort By:
Pageof 18
Health Promotion Journal of Australia : Official Journal of Australian Association of Health Promotion Professionals|August 19, 2025
A Journey Into School Lunchbox Decision-Making: A Mixed Methods Exploration of Australian ParentsWendy Boyd, Nasim Salehi, Frances Doran, et al.
Frontiers in Plant Science|December 7, 2018
Current Strategies of Polyploid Plant Genome Sequence AssemblyMaria Kyriakidou, Helen H Tai, Noelle L Anglin, et al.
Scientific Data|March 13, 2020
Genome assembly of six polyploid potato genomesMaria Kyriakidou, Noelle L Anglin, David Ellis, et al.
Plants (Basel, Switzerland)|January 25, 2025
Genotyping Genebank Collections: Strategic Approaches and Considerations for Optimal Collection ManagementNoelle L Anglin, Peter Wenzl, Vania Azevedo, et al.
Chemical Communications (Cambridge, England)|March 30, 2005
Fourteen-vertex homo- and heterobimetallic metallacarboranesDavid Ellis, Maria Elena Lopez, Ruaraidh McIntosh, et al.
Perfusion|April 20, 2023
Examining safety and efficacy of a fixed concentration heparin dosing strategy for anticoagulation in neonatal extracorporeal membrane oxygenationShambhavi Tewary, Sanket Sontakke, Kiri Dean, et al.
Familial Cancer|May 26, 2006
Low prevalence of BRCA1 exon rearrangements in familial and young sporadic breast cancer patientsDavid Ellis, Yogen Patel, Shu C Yau, et al.
Dalton Transactions (Cambridge, England : 2003)|October 15, 2013
Asymmetric 1,8/13,2,x-M2C2B10 14-vertex metallacarboranes by direct electrophilic insertion reactions; the VCD and BHD methods in critical analysis of cage C atom positionsAmelia McAnaw, Maria Elena Lopez, David Ellis, et al.
Dalton Transactions (Cambridge, England : 2003)|September 12, 2012
The synthesis and characterisation of homo- and heterobimetallic 1,14,2,9- and 1,14,2,10-M2C2B10 14-vertex metallacarboranesAmelia McAnaw, Maria Elena Lopez, David Ellis, et al.
Anesthesia and Analgesia|January 30, 2008
Intrathecal ziconotide for severe chronic pain: safety and tolerability results of an open-label, long-term trialMark S Wallace, Richard Rauck, Robert Fisher, et al.
Pageof 18